 | • レポートコード：MRC2104A007 • 出版社/出版日：Transparency Market Research / 2021年3月19日 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprise Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、世界の放射線性直腸炎市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、疾患別（急性放射線性直腸炎、慢性放射線性直腸炎）分析、治療別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの構成でまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場動向 ・世界の放射線性直腸炎市場規模：疾患別（急性放射線性直腸炎、慢性放射線性直腸炎） ・世界の放射線性直腸炎市場規模：治療別 ・世界の放射線性直腸炎市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Radiation Proctitis Market – Scope of the Report
TMR’s report on the global radiation proctitis market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global radiation proctitis market for the period 2018 – 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global radiation proctitis market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ Indication literature, annual reports, press releases, and relevant documents to understand the global radiation proctitis market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global radiation proctitis market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global radiation proctitis market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global radiation proctitis market. The next section of the global radiation proctitis market report highlights the USPs, which include epidemiology analysis, regulatory scenario, key industry events, technological advancements, and key success factors of top players operating in the global radiation proctitis market.
The report also delves into the competition landscape of the global radiation proctitis market. Key players operating in the global radiation proctitis market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global radiation proctitis market profiled in this report.
Key Questions Answered in Radiation Proctitis Market Report
What are the major drivers, restraints, and opportunities in the market?
What are the revenue share projections of key segments of the global radiation proctitis market during the forecast period?
Which segment is likely to lead the global radiation proctitis market in terms of revenue by 2030?
How mergers & acquisitions among players are widening the scope for the global radiation proctitis market?
What is the market position of different companies operating in the global radiation proctitis market?
Radiation Proctitis Market – Research Objectives and Research Approach
The comprehensive report on the global radiation proctitis market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the global radiation proctitis market. It is followed by market introduction, market dynamics, and an overview of the global radiation proctitis market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global radiation proctitis market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global radiation proctitis market. The next section of the global radiation proctitis market report highlights the USPs, which include regulatory scenario, epidemiology analysis, technological advancements, and key success factors of top players in the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global radiation proctitis market in terms of indication, therapy, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the radiation proctitis market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Radiation Proctitis market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Radiation Proctitis Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Prevalence of Urinary Incontinence, by Region
5.2. Key Industry Events
5.3. Regulatory Scenario
5.4. Technological Advancements
5.5. Key Success Factors of Top Players
6. Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication
6.1. Introduction & Definition
6.2. Global Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
6.2.1. Acute Radiation Proctitis
6.2.2. Chronic Radiation Proctitis
6.3. Global Radiation Proctitis Market Attractiveness Analysis, by Indication
7. Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy
7.1. Introduction & Definition
7.2. Global Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
7.2.1. Oral Therapy
7.2.1.1. Antidiarrheals
7.2.1.2. Anti-inflammatory Agents
7.2.1.3. Others
7.2.2. Ablative Procedures
7.2.3. Hyperbaric Oxygen Therapy
7.2.4. Formalin
7.2.5. Surgery
8. Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Region
8.1. Introduction
8.2. Radiation Proctitis Market Value Forecast, by Region, 2018–2030
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Radiation Proctitis Market Attractiveness Analysis, by Region
9. North America Radiation Proctitis Market Analysis and Forecast
9.1. Introduction
9.2. North America Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
9.2.1. Acute Radiation Proctitis
9.2.2. Chronic Radiation Proctitis
9.3. North America Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
9.3.1. Oral Therapy
9.3.1.1. Antidiarrheals
9.3.1.2. Anti-inflammatory Agents
9.3.1.3. Others
9.3.2. Ablative Procedures
9.3.3. Hyperbaric Oxygen Therapy
9.3.4. Formalin
9.3.5. Surgery
9.4. North America Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. North America Radiation Proctitis Market Attractiveness Analysis
9.5.1. By Indication
9.5.2. By Therapy
9.5.3. By Country/Sub-region
10. Europe Radiation Proctitis Market Analysis and Forecast
10.1. Introduction
10.2. Europe Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
10.2.1. Acute Radiation Proctitis
10.2.2. Chronic Radiation Proctitis
10.3. Europe Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
10.3.1. Oral Therapy
10.3.1.1. Antidiarrheals
10.3.1.2. Anti-inflammatory Agents
10.3.1.3. Others
10.3.2. Ablative Procedures
10.3.3. Hyperbaric Oxygen Therapy
10.3.4. Formalin
10.3.5. Surgery
10.4. Europe Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Radiation Proctitis Market Attractiveness Analysis
10.5.1. By Indication
10.5.2. By Therapy
10.5.3. By Country/Sub-region
11. Asia Pacific Radiation Proctitis Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
11.2.1. Acute Radiation Proctitis
11.2.2. Chronic Radiation Proctitis
11.3. Asia Pacific Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
11.3.1. Oral Therapy
11.3.1.1. Antidiarrheals
11.3.1.2. Anti-inflammatory Agents
11.3.1.3. Others
11.3.2. Ablative Procedures
11.3.3. Hyperbaric Oxygen Therapy
11.3.4. Formalin
11.3.5. Surgery
11.4. Asia Pacific Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Radiation Proctitis Market Attractiveness Analysis
11.5.1. By Indication
11.5.2. By Therapy
11.5.3. By Country/Sub-region
12. Latin America Radiation Proctitis Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
12.2.1. Acute Radiation Proctitis
12.2.2. Chronic Radiation Proctitis
12.3. Latin America Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
12.3.1. Oral Therapy
12.3.2. Ablative Procedures
12.3.3. Hyperbaric Oxygen Therapy
12.3.4. Formalin
12.3.5. Surgery
12.4. Latin America Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Radiation Proctitis Market Attractiveness Analysis
12.5.1. By Indication
12.5.2. By Therapy
12.5.3. By Country/Sub-region
13. Middle East & Africa Radiation Proctitis Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
13.2.1. Acute Radiation Proctitis
13.2.2. Chronic Radiation Proctitis
13.3. Middle East & Africa Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
13.3.1. Oral Therapy
13.3.1.1. Antidiarrheals
13.3.1.2. Anti-inflammatory Agents
13.3.1.3. Others
13.3.2. Ablative Procedures
13.3.3. Hyperbaric Oxygen Therapy
13.3.4. Formalin
13.3.5. Surgery
13.4. Middle East & Africa Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Radiation Proctitis Market Attractiveness Analysis
13.5.1. By Indication
13.5.2. By Therapy
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Global Radiation Proctitis Market Share Analysis, by Company, 2019
14.2. Company Profiles
14.2.1. Allergan plc
14.2.1.1. Company Description
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Teva Pharmaceutical Industries Ltd.
14.2.2.1. Company Description
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. Amneal Pharmaceuticals, Inc.
14.2.3.1. Company Description
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Pfizer, Inc.
14.2.4.1. Company Description
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. Mylan, Inc., (Viatris)
14.2.5.1. Company Description
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Sanofi
14.2.6.1. Company Description
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. Johnson & Johnson (Johnson & Johnson Consumer, Inc.)
14.2.7.1. Company Description
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Sun Pharmaceutical Industries Ltd.
14.2.8.1. Company Description
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. Environmental Tectonics Corporation
14.2.9.1. Company Description
14.2.9.2. Business Overview
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. Sechrist Industries, Inc.
14.2.10.1. Company Description
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis
Table 01: Radiation Proctitis: Clinical Trial Pipeline Analysis (1/2)
Table 02: Radiation Proctitis: Clinical Trial Pipeline Analysis (2/2)
Table 03: Estimated Number of Patients with Radiation Proctitis, by Key indications, by Key Countries 2020 (1/2)
Table 04: Estimated Number of Patients with Radiation Proctitis, by Key indications, by Key Countries 2020 (2/2)
Table 05: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 06: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030
Table 07: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030
Table 08: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 09: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 10: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 11: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030
Table 12: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030
Table 13: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 15: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030
Table 16: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030
Table 17: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 19: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030
Table 20: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030
Table 21: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 22: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 23: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030
Table 24: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030
Table 25: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 27: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030
Table 28: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030